Home › State-of-the-art equipment helps pharma companies get small molecule drugs to market faster
 

Keywords :   


State-of-the-art equipment helps pharma companies get small molecule drugs to market faster

2017-08-08 19:01:29| Canadian Plastics Headlines

Developing drugs in the pharmaceutical industry requires tools that enable thorough analytical analysis. But timing and cost are also critical. The post State-of-the-art equipment helps pharma companies get small molecule drugs to market faster appeared first on Canadian Plastics.

Tags: small market equipment companies

Category:Chemicals

Latest from this category

All news
04.05Weekly Recap: Sherwin-Williams, BASF, Abrafati Top This Weeks Stories
02.05Milestone for Transition to Sustainable Carbon in Europe
02.05Sherwin-Williams Launches High Performance Flooring Visualizer
01.05Axalta Releases First Quarter 2024 Results
01.05Brian Martin Joins AkzoNobel Automotive & Specialty Coatings
01.05Britt Meelby Jensen Nominated to Hempel A/S Board of Directors
01.05ACA Names Jeffrey J. Powell and Chase Bean to Board
30.04GEW Appoints GNG as Exclusive Distributor for Spain and Portugal
Chemicals »
04.05Weekly Recap: Sherwin-Williams, BASF, Abrafati Top This Weeks Stories
03.05'Garden floods show need to work with nature'
03.05Worst-ever job interviews: 'We had to crawl and moo'
03.05Have the wheels come off for Tesla?
03.05BW Converting focuses on time, energy and cost savings at INFOFLEX
03.05Navigator Paper Ups Offer for Accrual
03.05USDA urged to restore NASS surveys
03.05Dilo Hosts Open House
More »